Premier, Inc. (PINC)
NASDAQ: PINC · Real-Time Price · USD
18.10
+0.13 (0.70%)
Mar 14, 2025, 11:39 AM EDT - Market open
Premier Revenue
Premier had revenue of $240.27M in the quarter ending December 31, 2024, a decrease of -14.15%. This brings the company's revenue in the last twelve months to $1.29B, up 6.14% year-over-year. In the fiscal year ending June 30, 2024, Premier had annual revenue of $1.35B with 0.77% growth.
Revenue (ttm)
$1.29B
Revenue Growth
+6.14%
P/S Ratio
1.44
Revenue / Employee
$443,404
Employees
2,900
Market Cap
1.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 1.35B | 10.27M | 0.77% |
| Jun 30, 2023 | 1.34B | -96.81M | -6.76% |
| Jun 30, 2022 | 1.43B | -288.25M | -16.75% |
| Jun 30, 2021 | 1.72B | 421.56M | 32.44% |
| Jun 30, 2020 | 1.30B | 81.95M | 6.73% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
PINC News
- 10 days ago - Premier, Inc. to Participate in Leerink Global Healthcare Conference on March 11, 2025 - Business Wire
- 23 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Premier, Inc. (PINC) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 24 days ago - Premier, Inc. (PINC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 24 days ago - Premier, Inc. Enters Into $200 Million Accelerated Share Repurchase Program - Business Wire
- 25 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Premier, Inc. (PINC) Shareholders to Inquire about Securities Investigation - Accesswire
- 26 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Premier, Inc. (PINC) And Encourages Shareholders to Connect - Accesswire
- 4 weeks ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Premier, Inc. (PINC) And Encourages Investors to Connect - Accesswire
- 4 weeks ago - Bronstein, Gewirtz & Grossman, LLC Encourages Premier, Inc. (PINC) Stockholders to Inquire about Securities Investigation - Accesswire